Prospective preference assessment for the psilocybin for enhanced analgesia in chronic neuropathic pain trial

Authors
Category Systematic review
ConferenceCanadian Anesthesiologists Society Annual Meeting, CAS 2024
Year 2024
This article has no abstract
Epistemonikos ID: f9964e116b756558903e63d421f6cedefaf68b22
First added on: Feb 16, 2026